Page 94 - UCT2012 Health Sciences

Basic HTML Version

an unmasking TB-IRIS case. SAMJ South African Medical
Journal, 102(6): 512-517.
Williamson, A.-L., Rybicki, E.P., Shephard, E.G., Gray,
G., Bekker, L., Downing, K.J. and Williamson, C. 2012.
South African HIV-1 vaccine candidates the journey from
the bench to clinical trials. SAMJ South African Medical
Journal, 102(6): 452-455.
Wiysonge, C.S., Ngcobo, N.J., Jeena, P.M., Madhi, S.,
Schoub, B.D., Hawkridge, A.J., Shey, M. and Hussey, G.D.
2012. Advances in childhood immunisation in South Africa:
where to now? programme managers’ views and evidence
from systematic reviews. BMC Public Health, 12:578.
Wiysonge, C.S., Bradley, H., Volmink, J., Mayosi, B.M.,
Mbewu, A. and Opie, L.H. 2012. Beta-blockers for
hypertension. Cochrane Database of Systematic Reviews,
11: 1-80.
Wiysonge, C.S., Uthman, O.A., Ndumbe, P.M. and Hussey,
G.D. 2012. Individual and contextual factors associated
with low childhood immunisation coverage in sub-Saharan
Africa: a multilevel analysis. PLoS One, 7(5): e37905.
Wonkam, A., Ponde, C., Nicholson, N., Fieggen, K.,
Ramesar, R.S. and Davidson, A. 2012. The burden of sickle
cell disease in Cape Town. SAMJ South African Medical
Journal, 102(9): 752-754.
Wood, R., Racow, K., Bekker, L., Morrow, C.D., Middelkoop,
K., Mark, D. and Lawn, S.D. 2012. Indoor social networks in
a South African township: potential contribution of location
to tuberculosis transmission. PLoS One, 7(6): e39246.
Wood, R., Racow, K., Bekker, L., Middelkoop, K., Vogt, M.C.,
Kreiswirth, B. and Lawn, S.D. 2012. Lipoarabinomannan in
urine during tuberculosis treatment: association with host
and pathogen factors and mycobacteriuria. BMC Infectious
Diseases, 12:47.
Yone, E.W.P., Kuaban, C. and Kengne, A.P. 2012. HIV testing,
HIV status and outcomes of treatment for tuberculosis
in a major diagnosis and treatment centre in Yaounde,
Cameroon: a retrospective cohort study. BMC Infectious
Diseases, 12:190.
Zar, H.J., Eley, B.S., Nicol, M.P., Figaji, A.A. and Hawkridge,
A.J. 2012. Advances in childhood tuberculosis -
contributions from the University of Cape Town. SAMJ
South African Medical Journal, 102(6): 518-521.
Zawaira, A., Pooran, A., Barichievy, S. and Chopera, D. 2012.
A discussion of molecular biology methods for protein
engineering. Molecular Biotechnology, 51(1): 67-102.
Zhang, C., Denti, P., Van der Walt, J.-S., Ren, Y., Smith,
P.J., Karlsson, M.O. and McIlleron, H. 2012. Population
pharmacokinetic model for adherence evaluation using
lamivudine concentration monitoring. Therapeutic Drug
Monitoring, 34(4): 481-484.
Zhang, C., McIlleron, H., Ren, Y., Van der Walt, J.-S.,
Karlsson, M.O., Simonsson, U. andDenti, P. 2012. Population
pharmacokinetics of lopinavir and ritonavir in combination
with rifampicin - based antitubercular treatment in HIV-
infected children. Antiviral Therapy, 17: 25-33.
Zuhlke, L., Myer, L. and Mayosi, B.M. 2012. The promise of
computer-assisted auscultation in screening for structural
heart disease and clinical teaching. Cardiovascular Journal
of Africa, 23(7): 405-408.
Zumla, A., Abubaker, I., Raviglione, M., Hoelscher, M., Ditiu,
L., McHugh, T., B Squire, B., Cox, H., Ford, N., McNerney,
R., Marais, B., Grobusch, M.P., Lawn, S.D., Migliori, G.B.,
Mwaba, P., O’Grady, J., Pletschette, M., Ramsay, A.,
Chakaya, J., Schito, M., Swaminathan, S., Memish, Z.,
Maeurer, M. and Atun, R. 2012. Drug-resistant tuberculosis-
current dilemmas, unanswered questions, challenges, and
priority needs. Journal of Infectious Diseases, suppl 2(205):
S228 -S240.
Zvada, S.P., Denti, P., Geldenhuys, H.D., Meredith, S.A.,
Van As, D., Hatherill, M., Hanekom, W.A., Wiesner, L.,
Simonsson, U., Jindani, A., Harrison, T. and McIlleron,
H. 2012. Moxifloxacin population pharmacokinetics in
patients with pulmonary tuberculosis and the effect of
intermittent high-dose rifapentine. Antimicrobial Agents
and Chemotherapy, 56(8): 4471-4473.
Department of Obstetrics
and Gynaecology
Head of Department: Professor Lynette Denny
Departmental Profile
Our Mission Statement
• To provide high quality care to all women seeking our
• To foster a climate of intellectual enquiry
• To pursue excellence in research at every level of care
• To help create a world-class African University
Research is predominantly clinical and largely aligned
with our four sub-specialist areas: feto-maternal medicine,
gynaecological oncology, reproductive medicine and
urogynaecology. Research is conducted at all levels of